<DOC>
	<DOCNO>NCT00106678</DOCNO>
	<brief_summary>A number factor influence HIV-positive adolescent ' acceptance willingness continue take anti-HIV medicine . These factor include mental health substance abuse issue , barrier lack medical insurance , cognitive-behavioral barrier ( person 's impression impact medicine his/her health person 's sense his/her ability continue take medication prescribe ) . The purpose study use survey determine common specific barrier prevent HIV positive adolescent take anti-HIV medicine barrier cluster together . The information collect use develop validate schema classify HIV medication adherence barrier adherence cluster barrier adherence . This classification schema could use development intervention well meet need HIV-infected youth .</brief_summary>
	<brief_title>Typology Adherence Adolescents : Phase II</brief_title>
	<detailed_description>As HIV-infected adolescent identify link care , dyad medication medication adherence continue issue provider patient . Thus , develop strategy ass adherence barrier adherence population integral intervention target towards adolescent ' specific need . Our operate premise issue drug adherence multi-factorial intervention combine variety modality may prefer . However , intervention develop , must first develop tool use assess medication adherence identify barrier medication adherence population . This cross-sectional survey design assess prevalent combination barrier HIV medication adherence adolescent . Specific barrier focus study include mental health disorder , substance abuse , cognitive-behavioral structural barrier . In Phase II study , Adherence Staging Algorithm Participant Assessment Tool , pilot test modify base finding Phase I study , use determine prevalence specific barrier adherence among HIV-infected youth require antiretroviral medication common cluster specific barrier . A cognitive-behavioral barrier schema classify HIV medication adherence adolescent develop validate . The study consist one-time visit face-to-face interview complete two questionnaire : Adherence Staging Algorithm classify subject 's adherence his/her prescribe medication , Participant Assessment Tool ass prevalence barrier adherence subject may experience . The interview take 30 minute . In addition , patient 's medical record review HIV-related clinical data viral load , CD4 , history medication prescribe , barrier patient may experience mental health substance abuse problem .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Between age 12 year 24 year Eligible ART ( antiretroviral therapy ) base US Public Health Service guideline Have offer and/or prescribe HAART ( highly active antiretroviral therapy ) Ability give inform consent assent parental permission , require Infected HIV require ART Started HAART stop due medical reason , ( e.g. , change medication guideline , toxicity , resistance , etc . ) Females prescribed/receiving HAART purpose prevent mothertochild transmission</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Antiretroviral therapy ( ART )</keyword>
	<keyword>HAART</keyword>
	<keyword>Adherence</keyword>
	<keyword>Barriers</keyword>
</DOC>